Edward Inamine
Impact in
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
- Pharmaceutical Science top 5%
- Fluorine in Organic Chemistry
Papers in
- Pharmacology 12
- Microbial Natural Products and Biosynthesis 11
-
- Carbohydrate Chemistry and Synthesis 6
- Advanced Synthetic Organic Chemistry 2
- Co-authors
- Byron H. ArisonJoanne M. WilliamsonJerrold M. LieschDonald B. MelvilleA.L. DemainDorothy S. GenghofKenneth E. WilsonDavid Hendlin
- Journals
- The Journal of Antibiotics (7 papers)Journal of Biological Chemistry (6 papers)Archives of Biochemistry and Biophysics (4 papers)Journal of Industrial Microbiology & Biotechnology (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- United StatesJapan
In The Last Decade
Edward Inamine
26 papers receiving 656 citations
Peers
Comparison fields: 5 of 74
- Pharmacology 351
- Pharmaceutical Science 64
- Biotechnology 70
- Pharmacology 62
- Microbiology 5
Countries citing papers authored by Edward Inamine
This map shows the geographic impact of Edward Inamine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Inamine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Inamine more than expected).
Fields of papers citing papers by Edward Inamine
This network shows the impact of papers produced by Edward Inamine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Inamine. The network helps show where Edward Inamine may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Edward Inamine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 4 | |
| 2 | 1992 | 9 | |
| 3 | 1992 | 21 | |
| 4 | 1992 | 110 | |
| 5 | 1992 | 14 | |
| 6 | 1991 | 5 | |
| 7 | 1989 | 17 | |
| 8 | 1989 | 16 | |
| 9 | 1989 | 10 | |
| 10 | 1988 | 34 | |
| 11 | 1987 | 6 | |
| 12 | 1985 | 4 | |
| 13 | 1981 | 11 | |
| 14 | 1980 | 50 | |
| 15 | 1970 | 46 | |
| 16 | 1970 | 2 | |
| 17 | 1965 | 8 | |
| 18 | 1959 | 17 | |
| 19 | 1956 | 18 | |
| 20 | 1956 | 77 |
About Edward Inamine
Edward Inamine is a scholar working on Pharmacology, Organic Chemistry, Molecular Biology, Biotechnology and Pharmacy, having authored 26 papers that have together received 720 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (11 papers), Chemical Synthesis and Analysis (6 papers), Carbohydrate Chemistry and Synthesis (6 papers), Biopolymer Synthesis and Applications (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Advanced Synthetic Organic Chemistry (2 papers), Plant Disease Resistance and Genetics (2 papers) and Microbial Metabolites in Food Biotechnology (2 papers). The work is most often cited by research in Pharmacology (351 citations), Pharmaceutical Science (64 citations), Biotechnology (70 citations), Pharmacology (62 citations) and Microbiology (5 citations). Edward Inamine has collaborated with scholars based in United States and Japan. Frequent co-authors include Byron H. Arison, Joanne M. Williamson, Jerrold M. Liesch, Donald B. Melville, A.L. Demain, Dorothy S. Genghof, Kenneth E. Wilson, David Hendlin, Shuichi Iwadare and Alan W. Douglas. Their work appears in journals such as The Journal of Antibiotics, Journal of Biological Chemistry, Archives of Biochemistry and Biophysics, Journal of Industrial Microbiology & Biotechnology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.